06826 HAOHAI BIOTEC
- 35.950
- -1.050-2.84%
About HAOHAI BIOTEC Company
The company is a scientific and technological innovation enterprise that uses biomedical materials technology and genetic engineering technology for R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. The company was listed on the main board of the Hong Kong Stock Exchange and the Science and Technology Innovation Board of the Shanghai Stock Exchange on April 30, 2015 and October 30, 2019 respectively, becoming the first “Hong Kong Stock + Science and Technology Innovation Board” biomedical listed company in the country. The Group is a technology-innovative enterprise engaged in R&D, production and sales of medical devices and pharmaceuticals. It is committed to providing innovative medical products to the market through technological innovation and transformation, integration of domestic and foreign resources and large-scale production, gradually realizing import substitution of related pharmaceutical products, and becoming a leading enterprise in the field of biomedical materials. Main products: intraocular lenses, ophthalmic viscoelastic agents, corneal shaping lenses, PRL, hyaluronic acid, orthopedic joint cavity viscoelastic supplements, anti-adhesion and hemostasis, etc. The company has received honors such as the National Science and Technology Progress Award and the second prize of the National Science and Technology Progress Award.
Company Profile
Company Executives
- Name
- Position
- Salary
- yongtai hou
- Presidencies, Executive Director, Strategy Committee Members, Nomination Committee Members
- 2.29M
- jianying wu
- Executive Director, General Manager, Strategy Committee Members, Remuneration Committee Members
- 2.46M
- yiyi chen
- Executive Director
- 1.65M
- minjie tang
- Executive Director, Chief Financial Officer
- 1.84M
- jie you
- Non-executive Directors, Chairman of the Strategy Committee, Audit Committee Members, Nomination Committee Members
- --
- ming huang
- Non-executive Directors, Remuneration Committee Members, Strategy Committee Members, Authorized Representative
- 126.00K
- zhihong jiang
- Independent Non-Executive Director, Audit Committee Members
- 141.00K
- hongbo shen
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration and Assessment Committee Members, Nomination Committee Members
- --
- zhi su
- Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
- 126.00K
- yushe yang
- Independent Non-Executive Director, Strategy Committee Members
- 126.00K
- lei zhao
- Independent Non-Executive Director, Chairman of the Nomination Committee, Audit Committee Members, Remuneration Committee Members
- 126.00K
- yuanzhong liu
- Chairman of the Supervisory Board, Shareholder Supervisors
- --
- qing yang
- Independent Auditors
- 126.00K
- yuejun tang
- Independent Auditors
- 126.00K
- zhangzheng wei
- Employee Representative Supervisor
- 1.09M
- xiao song
- Employee Representative Supervisor
- 624.00K
- caixia ren
- Deputy General Manager
- --
- wenbin wang
- Deputy General Manager
- --
- jundong zhang
- Deputy General Manager
- --
- min tian
- Joint Company Secretary, Board Secretary
- --
- mingjing zhao
- Joint Company Secretary, Authorized Representative
- --
Analysis
Price Target
No Data
No Data